Recom Managed Systems to Begin Manufacture of Model 100 Heart Monitoring Devices
13 10월 2005 - 10:17PM
Business Wire
Recom Managed Systems (AMEX: RSY) announced today that it has
chosen Ventura, Calif.-based Ventrex, Inc. as its
contract-manufacturing partner. Ventrex exclusively manufactures
medical devices and has Fortune 100 companies among its clients.
Ventrex has produced a wide range of medical products and has
experience in producing monitoring devices that are similar to
Recom's Model 100 in function and design. "The agreement with
Ventrex to serve as our contract manufacturer is an important
milestone for Recom," said Rod Hildebrandt, chief operating officer
of Recom. "We were very diligent in our search for a manufacturer
because it was important to us to find a quality organization like
Ventrex with which we could partner for the long term. We are
excited to begin the commercial production of the Recom Model 100."
"We are pleased and honored to be selected as Recom's partner in
the manufacture of their very promising new product," said Bob
Guthrie, general manager of Ventrex. "The technology employed in
this unique device fits well with our core capabilities. We are
confident that this will be a long and mutually beneficial
relationship." Ventrex is privately owned by its on-site management
team, who have more than 20 years of experience in all facets of
medical-device manufacturing. Ventrex's manufacturing facility is
FDA-approved and ISO 13485-certified. The company has experienced
seven years of steady growth while establishing a very impressive
track record of producing high-quality products at competitive
costs, and their on-time delivery rate is more than 98 percent.
Recom and Ventrex have jointly initiated component part acquisition
in order to commence production of the Model 100 as soon as
practicable and definitely toward the end of the current calendar
quarter. About Recom Managed Systems, Inc. Recom Managed Systems,
Inc. is an emerging life-sciences company focused on the monitoring
and detection of disease through continuous biomedical signal
monitoring. Recom Managed Systems, Inc. uses its patented signal
technology to design and develop medical devices that simplify and
reduce the costs of diagnostic testing and patient monitoring in an
ambulatory setting. With its patented signal-technology platform,
Recom brings clinical-quality physiological signal monitoring to
the ambulatory setting. Recom's first product, the Model 100 Heart
Monitor, is an ambulatory patient heart monitor that uses patented
signal-processing technology to record a clinical-quality ECG
signal in the presence of interference generated by the patient's
body movements and ambient environment. The Model 100 has received
510(k) clearance from the Food and Drug Administration. Recom
Managed Systems, Inc. is traded on the American Stock Exchange
under the symbol RSY. More information is located at
http://www.recom-systems.com Caution Regarding Forward-Looking
Statements Statements in this release that are not strictly
historical are "forward-looking" statements. Forward-looking
statements involve known and unknown risks, which may cause Recom's
actual results in the future to differ materially from expected
results. Factors which could cause or contribute to such
differences include, but are not limited to, failure to complete
the development and introduction of new products or services,
failure to obtain federal or state regulatory approvals governing
medical devices, monitoring and other related services or products,
inability to obtain physician, patient or insurance acceptance of
Recom's products or services, adverse equity-market conditions and
declines in the value of Recom's common stock, and the
unavailability of financing to complete management's plans and
objectives. These risks are qualified in their entirety by
cautionary language and risk factors set forth and to be further
described in Recom's filings with the Securities and Exchange
Commission.
Merrill Lynch & Co. Strategic Return Notes Linked TO The Select 10 Index (AMEX:RSY)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Merrill Lynch & Co. Strategic Return Notes Linked TO The Select 10 Index (AMEX:RSY)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024
Merrill Lynch & Co. Strategic Return Notes Linked TO The Select 10 Index (아메리카 증권거래소)의 실시간 뉴스: 최근 기사 0
More Recom Managed Systems, Inc. News Articles